07:33 EDT Regeneron to acquire Decibel Therapeutics for $4.00 per share plus CVR
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on REGN:
- Decibel Therapeutics (NASDAQ:DBTX) Skyrockets On Acquisition By Regeneron
- Regeneron to Acquire Decibel Therapeutics, Strengthening Gene Therapy and Hearing Loss Programs
- Cantor biotech/biopharma analysts to hold analyst/industry conference call
- Regeneron price target raised to $950 from $900 at Oppenheimer
- Regeneron Reports Second Quarter 2023 Financial and Operating Results